AIDS dementia complex in the Italian National AIDS Registry: Temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection

Journal of the Neurological Sciences

Volumn 144, Issue 1-2, 1996, Pages 107-113

  Chiesi, Antonio ^a   Seeber, Angela C ^a   Dally, Leonard G ^a   Floridia, Marco ^a   Rezza, Giovanni ^a   Vella, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS; AIDS dementia complex; IVDU transmission category

Indexed keywords

ADULT; ARTICLE; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS DEMENTIA COMPLEX; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; FEMALE; HIV-1; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0030447037     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00192-X     Document Type: Article

References (28)

1. Bacellar H., Munoz A., Miller E.N.et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS cohort Study, 1985-1992. Neurology. 44:1994;1892-1900.
2. Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 36((suppl 1)):1987;1S-15S.
3. Centers for Disease Control (1993) 1993 Revised Classification System for HIV infection and Expanded Surveillance Case Definition for AIDS Among Adolescent and Adults. MMWR. 41:1993;1-19.
4. Chiesi, A., Dally, L.G., D'Alessandro, M., et al. (1993) Factors influencing neuropsychological performance in HIV infected individuals [Abstract]. Presented at the IX° Intern. Conf. on AIDS, Berlin, Abstract Book PO-B16-1772.
5. Chiesi A., Vella S., Dally L.G.et al. Epidemiology of AIDS dementia complex in Europe. J. AIDS Hum. Retrovir. 11:1996;39-44.
6. De Gans J., Lange J.M.A., Derix M.M.A.et al. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose Zidovudine. AIDS. 2:1988;37-40.
7. Dournon, E., Matheron, S., Rozenbaum, W. et al. (1988) Effect of Zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet, ii, 1297-1302.
8. Geleziunas R., Schipper H.M., Wainberg M.A. Pathogenesis and therapy of HIV-1 infection of the central nervous system. AIDS. 6:1992;1411-1426.
9. Goudsmit, J., De Wolf, F., Paul, D.A. et al. (1986) Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic HIV infection. Lancet, ii:177-80.
10. Grant I., Atkinson J.H., Hesselink J.R.et al. Evidence of early central nervous system involvement in acquired immunodeficiency syndrome and other human immunodeficiency virus infections. Ann. Intern. Med. 107:1987;828-836.
11. Gulevich S.J., McCutchan J.A., Thal L.J.et al. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus. J. AIDS. 6:1993;1002-1007.
12. Ho D.D., Bredesen D.E., Vinters H.V., Daar E.S. The AIDS dementia complex. Annals of Internal Medicine. 111:1989;400-410.
13. Janssen R.S., Nwanyanwu O.C., Selik R.M., Stehr-Green J.K. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 42:1992;1472-1476.
14. Levy, R.M., Bredesen, D.E. (1988) Central nervous system dysfunction in acquired immunodeficiency syndrome. In AIDS and the Nervous System. Edited by Rosenblum M.L., Levy, R.M., Bredesen, D.E. New York: Raven Press: 29-63.
15. Levy, R.M., Janssen, R.S., Bush, T.J., Rosenblum, M.L. (1988) Neuroepidemiology of acquired immunodeficiency syndrome. In AIDS and the Nervous System. Edited by Rosenblum M.L., Levy, R.M., Bredesen, D.E. New York: Raven Press: 13-17.
16. Maj M. Organic mental disorders in HIV-1 infection. AIDS. 4:1990;831-840.
17. McArthur J.C. Neurologic manifestations of AIDS. Medicine. 66:1987;407-437.
18. Navia B.A., Cho E.S., Petito C.K., Price R.W. The AIDS dementia complex. II. Neuropathology Ann. Neurol. 19:1986;525-535.
19. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex. I. Clinical fetures Ann. Neurol. 19:1986;517-524.
20. Portegies P., Epstein L.G., Tjong A.et al. HIV type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status. Ann. Neurol. 46:1989;261-264.
21. Portegies P., Henting R.H., De Gans J.et al. Presentation and course of AIDS dementia complex: 10 years of follow up in Amsterdam. The Netherlands. AIDS. 7:1993;669-675.
22. Power C., Selnes O.A., Grim J.A., Mc Arthur J.C. HIV dementia Scale: A Rapid Screening Test. J. of AIDS and Hum. Retrovir. 8:1995;273-278.
23. Price R.W., Brew B.J. The AIDS dementia complex. J Infect Dis. 158:1988;1079-1083.
24. Price R.W., Brew B., Sidtis J.et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592.
25. Price, R.W., Brew, B., Roke, M. (1992) Central and peripheral nervous system complications of HIV-1 infection and AIDS. In AIDS, Etiology, Diagnosis, Treatment and Prevention. Edited by De Vita V.T., Hellman, S., Rosenberg, S.A., Philadelphia: J.B. Lippincott Company: 237-257.
26. Rosei M.A., Pigorini F., Bernabei A.et al. Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1-infected subjects. AIDS. 6:1992;1309-1316.
27. Working Group of the American Academy of neurology AIDS Task Force Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 41:1991;778-785.
28. Yarchoan, R., Berg, G., Brouwers, P. et al. (1987) Response of human-immunodeficiency-virus-associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet, i: 132-135.